30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now
United States Biotechnology & Medical Research

Orchestra Therapeutics Inc (OCHTQ)

Track

Stock chart
Ticker: OCHTQ Exchange: PNK
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Top insiders
Trades
GREEN MICHAEL K
COO and CFO
1 sale — total 4,751,808 USD
Sale 9 Nov 2006
Value US$3,483,230.21 | Price 428.81 | Shares 8,858
Sale 8 Nov 2006
Value US$2,088,857.42 | Price 112.36 | Shares 95,584
Sale 7 Nov 2006
Value US$621,896.00 | Price 1.91 | Shares 325,600
Sale 6 Nov 2006
Value US$301,780.00 | Price 1.91 | Shares 158,000
Sale 3 Nov 2006
Value US$2,001,600.00 | Price 1.92 | Shares 1,042,500
Sale 2 Nov 2006
Value US$2,040,360.00 | Price 1.96 | Shares 1,041,000
Sale 1 Nov 2006
Value US$649,350.00 | Price 1.95 | Shares 333,000
Sale 31 Oct 2006
Value US$706,450.00 | Price 1.99 | Shares 355,000
Sale 19 Oct 2006
Value US$1,440,000.00 | Price 2.00 | Shares 720,000
Sale 15 Sep 2006
Value US$300,000.00 | Price 2.00 | Shares 150,000
Sale 8 Sep 2006
Value US$4,360,000.00 | Price 2.00 | Shares 2,180,000
Sale 31 Aug 2006
Value US$400,000.00 | Price 2.00 | Shares 200,000
Sale 29 Aug 2006
Value US$500,000.00 | Price 2.00 | Shares 250,000
Sale 25 Aug 2006
Value US$500,000.00 | Price 2.00 | Shares 250,000
Buy 21 Aug 2006
Value US$9,000.00 | Price 0.02 | Shares 500,000
Buy 28 Jul 2006
Value US$59,800.00 | Price 0.02 | Shares 2,600,000
Buy 27 Jul 2006
Value US$6,600.00 | Price 0.02 | Shares 300,000
Buy 19 Jun 2006
Value US$4,000.00 | Price 0.02 | Shares 200,000
Buy 14 Jun 2006
Value US$10,000.00 | Price 0.02 | Shares 500,000
Sale 30 Dec 2005
Value US$0.00 | Price 0.00 | Shares 3,496,000
Buy 22 Sep 2005
Value US$0.00 | Price 0.00 | Shares 9,643,060
Buy 6 Sep 2005
Value US$14,886.00 | Price 0.50 | Shares 30,000
Buy 2 Sep 2005
Value US$4,600.00 | Price 0.46 | Shares 10,000
Buy 19 May 2004
Value US$10,082.00 | Price 1.42 | Shares 7,100
Buy 18 May 2004
Value US$7,050.00 | Price 1.41 | Shares 5,000
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2007-04-30 2006-11-09 S Sale GREEN MICHAEL K

COO and CFO

Officer
8,858 +22.8%
428.81
US$3,483,230 		8,858 +22.8% 428.81 US$3,483,230
2007-04-30 2006-11-08 S Sale GREEN MICHAEL K

COO and CFO

Officer
95,584 -23.7%
112.36
US$2,088,857 		95,584 -23.7% 112.36 US$2,088,857
2007-04-30 2006-11-07 S Sale GREEN MICHAEL K

COO and CFO

Officer
28,758 -14.3%
232.25
US$4,040,776 		28,758 -14.3% 232.25 US$4,040,776
2007-04-30 2006-11-06 S Sale GREEN MICHAEL K

COO and CFO

Officer
158,000 -2.9%
1.91
US$301,780 		158,000 -2.9% 1.91 US$301,780
2007-04-30 2006-11-03 S Sale GREEN MICHAEL K

COO and CFO

Officer
1,042,500 -16.2%
1.92
US$2,001,600 		1,042,500 -16.2% 1.92 US$2,001,600
2007-04-30 2006-11-02 S Sale GREEN MICHAEL K

COO and CFO

Officer
1,041,000 -13.9%
1.96
US$2,040,360 		1,041,000 -13.9% 1.96 US$2,040,360
2007-04-30 2006-11-01 S Sale GREEN MICHAEL K

COO and CFO

Officer
333,000 -4.3%
1.95
US$649,350 		333,000 -4.3% 1.95 US$649,350
2007-04-30 2006-10-31 S Sale GREEN MICHAEL K

COO and CFO

Officer
355,000 -4.4%
1.99
US$706,450 		355,000 -4.4% 1.99 US$706,450
2007-04-30 2006-10-19 S Sale THEOFAN GEORGIA

VP, Clinical Development

Officer
720,000 -88.8%
2.00
US$1,440,000 		720,000 -88.8% 2.00 US$1,440,000
2007-04-30 2006-09-15 S Sale THEOFAN GEORGIA

VP, Clinical Development

Officer
150,000 -16.0%
2.00
US$300,000 		150,000 -16.0% 2.00 US$300,000
2007-04-30 2006-09-08 S Sale THEOFAN GEORGIA

VP, Clinical Development

Officer
2,180,000 -70.0%
2.00
US$4,360,000 		2,180,000 -70.0% 2.00 US$4,360,000
2007-04-30 2006-08-31 S Sale THEOFAN GEORGIA

VP, Clinical Development

Officer
200,000 -6.0%
2.00
US$400,000 		200,000 -6.0% 2.00 US$400,000
2007-04-30 2006-08-29 S Sale THEOFAN GEORGIA

VP, Clinical Development

Officer
250,000 -7.0%
2.00
US$500,000 		250,000 -7.0% 2.00 US$500,000
2007-04-30 2006-08-25 S Sale THEOFAN GEORGIA

VP, Clinical Development

Officer
250,000 -6.6%
2.00
US$500,000 		250,000 -6.6% 2.00 US$500,000
2006-08-25 2006-08-21 B Purchase Hochman David P Non-Executive Director
500,000 +17.4%
0.02
US$9,000 		500,000 +17.4% 0.02 US$9,000
2006-08-01 2006-07-28 B Purchase Hochman David P Non-Executive Director
2,600,000 +inf%
0.02
US$59,800 		2,600,000 +inf% 0.02 US$59,800
2006-08-01 2006-07-27 B Purchase Hochman David P Non-Executive Director
300,000 +11.7%
0.02
US$6,600 		300,000 +11.7% 0.02 US$6,600
2006-08-01 2006-06-19 B Purchase Hochman David P Non-Executive Director
200,000 +8.4%
0.02
US$4,000 		200,000 +8.4% 0.02 US$4,000
2006-06-15 2006-06-14 B Purchase Hochman David P Non-Executive Director
500,000 +26.7%
0.02
US$10,000 		500,000 +26.7% 0.02 US$10,000
2005-12-30 2005-12-30 S Sale KIMBERLIN KEVIN Non-Executive Director Large shareholder
3,496,000
0.00
US$0 		3,496,000 0.00 US$0
2005-10-03 2005-09-22 B Purchase KIMBERLIN KEVIN Non-Executive Director Large shareholder
9,643,060
0.00
US$0 		9,643,060 0.00 US$0
2005-09-06 2005-09-06 B Purchase GREEN MICHAEL K

VP, Finance and CFO

Officer
30,000 +113.3%
0.50
US$14,886 		30,000 +113.3% 0.50 US$14,886
2005-09-06 2005-09-02 B Purchase BONFIGLIO JOHN N

CEO

Executive Director
10,000 +31.0%
0.46
US$4,600 		10,000 +31.0% 0.46 US$4,600
2004-05-19 2004-05-19 B Purchase
GREEN MICHAEL K

VP, Finance and CFO
7,100 +inf%
1.42
US$10,082 		7,100 +inf% 1.42 US$10,082
2004-05-19 2004-05-18 B Purchase
BONFIGLIO JOHN N

CEO

Executive Director
5,000 +inf%
1.41
US$7,050 		5,000 +inf% 1.41 US$7,050
Explore more

More insider trading research around Orchestra Therapeutics Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America